REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 50 filers reported holding REGULUS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $33,000 | -41.1% | 20,243 | -18.8% | 0.00% | – |
| Q4 2016 | $56,000 | -31.7% | 24,940 | 0.0% | 0.00% | – |
| Q3 2016 | $82,000 | +13.9% | 24,940 | 0.0% | 0.00% | – |
| Q2 2016 | $72,000 | -81.1% | 24,940 | -54.6% | 0.00% | -100.0% |
| Q1 2016 | $381,000 | -19.1% | 54,973 | +1.8% | 0.00% | 0.0% |
| Q4 2015 | $471,000 | +292.5% | 53,984 | +195.1% | 0.00% | +100.0% |
| Q3 2015 | $120,000 | -40.3% | 18,295 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $201,000 | +6.3% | 18,295 | +63.6% | 0.00% | 0.0% |
| Q1 2015 | $189,000 | +2.2% | 11,180 | -3.0% | 0.00% | 0.0% |
| Q4 2014 | $185,000 | +156.9% | 11,528 | +9.2% | 0.00% | – |
| Q3 2014 | $72,000 | -12.2% | 10,560 | +2.9% | 0.00% | – |
| Q2 2014 | $82,000 | +13.9% | 10,258 | +27.9% | 0.00% | – |
| Q1 2014 | $72,000 | +22.0% | 8,023 | 0.0% | 0.00% | – |
| Q4 2013 | $59,000 | -22.4% | 8,023 | 0.0% | 0.00% | – |
| Q3 2013 | $76,000 | -8.4% | 8,023 | -4.8% | 0.00% | – |
| Q2 2013 | $83,000 | – | 8,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $2,943,000 | 1.62% |
| HealthCor Management, L.P. | 1,575,000 | $14,207,000 | 0.86% |
| Cormorant Asset Management, LP | 200,000 | $1,804,000 | 0.42% |
| BVF INC/IL | 184,999 | $1,669,000 | 0.26% |
| Verity Asset Management, Inc. | 28,410 | $244,000 | 0.25% |
| Callan Capital, LLC | 80,478 | $726,000 | 0.24% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 225,000 | $2,029,000 | 0.22% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 61,846 | $558,000 | 0.05% |
| LMR Partners LLP | 11,815 | $106,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 70,000 | $631,000 | 0.01% |